Precision Oncology & Rare Cancers: Insights from Dr. Razelle Kurzrock | 1Cell.Ai

What does the future of cancer treatment look like? How is precision oncology transforming the way we understand and treat rare and complex cancers? In this insightful conversation, Dr. Razelle Kurzrock, a globally recognized leader in precision oncology and rare cancer research, shares her perspectives on the evolving landscape of cancer care, precision medicine, genomics, and innovative therapeutic approaches. Dr. Kurzrock serves as: Associate Director of Clinical Research at the Medical College of Wisconsin Cancer Center Associate Director of Precision Oncology at the Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine Founding Director of the Michels Rare Cancers Research Laboratories at the MCW Cancer Center Chair of the Early Therapeutics and Rare Cancers Committee at SWOG NCI Recognized as one of the world's leading voices in precision medicine and among the most highly cited scientists globally, Dr. Kurzrock has authored more than 950 scientific and medical publications. She has served as Principal Investigator for more than 100 early-phase clinical trials and has contributed to the development of eight life-changing drugs approved by the FDA. In 2022, Dr. Kurzrock and the DART Rare Cancer Study team received the National Cancer Institute Director's Award of Merit for their outstanding contributions to rare cancer research. Watch this conversation to explore the future of precision oncology, genomic medicine, rare cancers, personalized cancer treatment, and next-generation cancer therapeutics. About 1Cell.Ai 1Cell.Ai is advancing precision oncology through innovative genomic and AI-powered solutions designed to support more informed and personalized cancer care. Subscribe to the 1Cell.Ai YouTube channel for conversations with leading oncologists, researchers, and healthcare experts exploring the future of cancer diagnostics and precision medicine. Hashtags: Precision Oncology, Rare Cancers, Dr Razelle Kurzrock, Cancer Research, Precision Medicine, Personalized Cancer Treatment, Genomic Medicine, Cancer Genomics, Rare Cancer Research, Oncology Research, Cancer Therapeutics, Molecular Oncology, Targeted Cancer Therapy, Clinical Trials, Early Phase Clinical Trials, AI in Oncology, Precision Cancer Care, Medical Oncology, Cancer Diagnostics, 1Cell.Ai #PrecisionOncology #CancerResearch #PrecisionMedicine #RareCancers #CancerCare #Oncology #CancerGenomics #PersonalizedMedicine #CancerTreatment #1CellAi